Information Provided By:
Fly News Breaks for June 21, 2016
WBMD
Jun 21, 2016 | 08:17 EDT
Pacific Crest expects WebMD to benefit from "a historically strong pipeline of highly-targeted and complex drug therapies coming to market." The firm adds that the lack of pricing pressures on drugs whose patents are expiring also bodes well for pharma marketing budgets and for WebMD. The firm keeps a $74 price target and Overweight rating on WebMD.
News For WBMD From the Last 2 Days
There are no results for your query WBMD